1. Home
  2. BMHL vs ONCY Comparison

BMHL vs ONCY Comparison

Compare BMHL & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BMHL

Bluemount Holdings Limited Class B Ordinary Shares

HOLD

Current Price

$5.75

Market Cap

100.8M

Sector

N/A

ML Signal

HOLD

Logo Oncolytics Biotech Inc.

ONCY

Oncolytics Biotech Inc.

HOLD

Current Price

$0.92

Market Cap

98.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BMHL
ONCY
Founded
2016
1998
Country
Hong Kong
Canada
Employees
9
N/A
Industry
Pharmaceuticals and Biotechnology
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
100.8M
98.7M
IPO Year
N/A
2002

Fundamental Metrics

Financial Performance
Metric
BMHL
ONCY
Price
$5.75
$0.92
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$7.33
AVG Volume (30 Days)
17.8K
1.7M
Earning Date
06-13-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$2,505.00
P/E Ratio
$66.66
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.72
$0.69
52 Week High
$6.35
$1.51

Technical Indicators

Market Signals
Indicator
BMHL
ONCY
Relative Strength Index (RSI) 69.23 52.50
Support Level $3.24 $0.90
Resistance Level $6.35 $1.18
Average True Range (ATR) 0.48 0.06
MACD 0.03 0.01
Stochastic Oscillator 79.49 58.04

Price Performance

Historical Comparison
BMHL
ONCY

About BMHL Bluemount Holdings Limited Class B Ordinary Shares

Bluemount Holdings Ltd through its operating subsidiaries, it is a Hong Kong-based consulting and advisory and financial services provider, as well as trader of commodities such as luxury timepieces. The financial services includes underwriting and placing services, securities dealing and brokerage services, and asset management services. It provides comprehensive consulting and advisory services on business development strategies to its diverse clientele. Generally, the company provides consulting and advisory business for the following segments: Corporate Finance; and Strategic Communications.

About ONCY Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer, among others.

Share on Social Networks: